BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36151845)

  • 1. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
    Jogiat UM; Bédard ELR; Sasewich H; Turner SR; Eurich DT; Filafilo H; Baracos V
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2630-2636. PubMed ID: 36151845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
    Jogiat UM; Sasewich H; Turner SR; Baracos V; Eurich DT; Filafilo H; Bédard ELR
    Ann Surg; 2022 Nov; 276(5):e311-e318. PubMed ID: 35794004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
    Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
    Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
    Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
    Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.
    Wang P; Wang S; Li X; Lin G; Ma Y; Xiao R; Li H; Qiu M; Yang F
    Int J Surg; 2022 Jan; 97():106206. PubMed ID: 34990833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
    Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
    Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
    Shachar SS; Williams GR; Muss HB; Nishijima TF
    Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
    BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis.
    Findlay M; White K; Stapleton N; Bauer J
    Clin Nutr; 2021 Apr; 40(4):1711-1718. PubMed ID: 32994071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
    Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
    Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy.
    Sato S; Kunisaki C; Suematsu H; Tanaka Y; Miyamoto H; Kosaka T; Yukawa N; Tanaka K; Sato K; Akiyama H; Endo I
    In Vivo; 2018; 32(3):603-610. PubMed ID: 29695567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.
    Stangl-Kremser J; Suarez-Ibarrola R; Andrea D; Korn SM; Pones M; Kramer G; Marhold M; Krainer M; Enikeev DV; Glybochko PV; Tamandl D; Shariat SF; Baltzer P
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):309-315. PubMed ID: 31745255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
    Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
    Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.